1. Home
  2. VERB vs UNCY Comparison

VERB vs UNCY Comparison

Compare VERB & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • UNCY
  • Stock Information
  • Founded
  • VERB 2014
  • UNCY 2016
  • Country
  • VERB United States
  • UNCY United States
  • Employees
  • VERB N/A
  • UNCY N/A
  • Industry
  • VERB Other Consumer Services
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERB Consumer Discretionary
  • UNCY Health Care
  • Exchange
  • VERB Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • VERB 7.4M
  • UNCY 31.9M
  • IPO Year
  • VERB N/A
  • UNCY 2021
  • Fundamental
  • Price
  • VERB $10.88
  • UNCY $0.45
  • Analyst Decision
  • VERB Strong Buy
  • UNCY Strong Buy
  • Analyst Count
  • VERB 1
  • UNCY 4
  • Target Price
  • VERB $800.00
  • UNCY $5.13
  • AVG Volume (30 Days)
  • VERB 2.9M
  • UNCY 1.5M
  • Earning Date
  • VERB 11-12-2024
  • UNCY 11-12-2024
  • Dividend Yield
  • VERB N/A
  • UNCY N/A
  • EPS Growth
  • VERB N/A
  • UNCY N/A
  • EPS
  • VERB N/A
  • UNCY N/A
  • Revenue
  • VERB $102,000.00
  • UNCY N/A
  • Revenue This Year
  • VERB $547.62
  • UNCY N/A
  • Revenue Next Year
  • VERB $300.00
  • UNCY N/A
  • P/E Ratio
  • VERB N/A
  • UNCY N/A
  • Revenue Growth
  • VERB 684.62
  • UNCY N/A
  • 52 Week Low
  • VERB $5.05
  • UNCY $0.20
  • 52 Week High
  • VERB $184.60
  • UNCY $1.82
  • Technical
  • Relative Strength Index (RSI)
  • VERB 50.96
  • UNCY 66.31
  • Support Level
  • VERB $9.20
  • UNCY $0.35
  • Resistance Level
  • VERB $16.13
  • UNCY $0.41
  • Average True Range (ATR)
  • VERB 2.30
  • UNCY 0.03
  • MACD
  • VERB 0.41
  • UNCY 0.01
  • Stochastic Oscillator
  • VERB 52.62
  • UNCY 97.37

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Share on Social Networks: